Medivation Free Cash Flow:
-47.11M for Dec. 31, 2012Medivation Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -47.11M |
| Sept. 30, 2012 | -8.00M |
| June 30, 2012 | -40.07M |
| March 31, 2012 | -21.52M |
| Dec. 31, 2011 | -25.89M |
| Sept. 30, 2011 | -19.05M |
| June 30, 2011 | -14.65M |
| March 31, 2011 | |
| Dec. 31, 2010 | -3.59M |
| Sept. 30, 2010 | -21.91M |
| June 30, 2010 | -22.21M |
| March 31, 2010 | -27.55M |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
MDVN Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Dendreon | -58.40M |
| Johnson & Johnson | 1.691B |
| Targacept | -11.80M |
MDVN Free Cash Flow Rankings
| Overall |
49th percentile 4074 of 8002 |
| Sector |
21st percentile 536 of 684 in Healthcare |
| Industry |
26th percentile 182 of 248 in Biotechnology |
MDVN Free Cash Flow Range, Past 5 Years
| Minimum | -47.11M | Dec 2012 |
| Maximum | 200.33M | Dec 2008 |
| Average | -4.857M |
MDVN News
Medivation, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 01:00 PM
Seeking Alpha May 20
Seeking Alpha May 20
